Chronic nitric oxide inhibition model six years on

Hypertension

Volumn 32, Issue 6, 1998, Pages 958-964

  Zatz, Roberto ^a,c   Baylis, Christine ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Lab de Fisiopatologia Renal   (Brazil)

Author keywords

Blood pressure; Cardiovascular diseases; Models; Nitric oxide; Nitric oxide synthase; Renin angiotensin system; Vasodilation

Indexed keywords

ARACHIDONIC ACID DERIVATIVE; CALCIUM CHANNEL; ENDOTHELIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADRENERGIC SYSTEM; BIOSYNTHESIS; CENTRAL NERVOUS SYSTEM; ENZYME INHIBITION; HEMODYNAMICS; HYPERTENSION; INJURY; KIDNEY BLOOD FLOW; MODEL; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SODIUM RETENTION;

EID: 0032406782     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.32.6.958     Document Type: Review

References (106)

1. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biologic activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
2. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A. 1987;84:9265-9269.
3. Kone BC, Baylis C. Biosynthesis and homeostatic roles of nitric oxide in the kidney. Am J Physiol. 1997;272:F561-F578.
4. Ito S. Nitric oxide in the kidney. Curr Opin Nephrol Hypertens. 1995; 4:23-30.
5. Bachmann S, Mundel P. Nitric oxide in the kidney: synthesis, localization and function. Am J Kidney Dis. 1994;24:112-129.
6. Tseng CJ, Liu HY, Lin HC, Ger LP, Tung CS, Yen MH. Cardiovascular effects of nitric oxide in the brain stem nuclei of rats. Hypertension. 1996;27:36-42.
7. Okamura T, Yoshida K, Toda N. Nitroxidergic innervation in dog and monkey renal arteries. Hypertension. 1995;25:1090-1095.
8. Zou AP, Cowley AW. Nitric oxide in renal cortex and medulla. An in vivo microdialysis study. Hypertension. 1997;29:194-198.
9. Boegehold MA. Heterogeneity of endothelial function within the circulation. Curr Opin Nephrol Hypertens. 1998;7:71-78.
10. Zhang K, Mayhan WG, Patel KP. Nitric oxide within the paraventricular nucleus mediates changes in renal sympathetic nerve activity. Am J Physiol. 1997;273:R864-R872.
11. Rees DD, Palmer RM, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A. 1989;86:3375-3378.
12. Haynes WG, Noon JP, Walker BR, Webb DJ. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens. 1993;11:1375-1380.
13. Wolzt M, Schmetterer L, Ferber W, Artner E, Mensik C, Eichler HG, Krejcy K. Effect of nitric oxide synthase inhibition on renal hemodynamics in humans: reversal by L-arginine. Am J Physiol. 1997;272: F178-F182.
14. Granger JP, Alberola AM, Salazar FJ, Nakamura T. Control of renal hemodynamics during intrarenal and systemic blockade of nitric oxide synthesis in conscious dogs. J Cardiovasc Pharmacol. 1992;20: S160-S162.
15. Zatz R, De-Nucci G. Effects of acute nitric oxide inhibition on rat glomerular microcirculation. Am J Physiol. 1991;261:F360-F363.
16. Deng A, Baylis C. Locally produced EDRF controls preglomerular resistance and ultrafiltration coefficient. Am J Physiol. 1993;264: F212-F215.
17. De-Nicola L, Blantz RC, Gabbai FB. Nitric oxide and angiotensin II. Glomerular and tubular interaction in the rat. J Clin Invest. 1992;89: 1248-1256.
18. Schultz PJ, Schorer AE, Raij L. Effects of endothelium-derived relaxing factor and nitric oxide on rat mesangial cells. Am J Physiol. 1990;258: F162-F167.
19. McKee M, Scavone C, Nathanson JA. Nitric oxide, cGMP, and hormone regulation of active sodium transport. Proc Natl Acad Sci U S A. 1994; 91:12056-12060.
20. Stoos BA, Garcia NH, Garvin JL. Nitric oxide inhibits sodium reabsorption in the isolated perfused cortical collecting duct. J Am Soc Nephrol. 1995;6:89-94.
21. Shultz PJ, Tolins JP. Adaptation to increased dietary salt intake in the rat. Role of endogenous nitric oxide. J Clin Invest. 1993;91:642-650.
22. Deng X, Welch WJ, Wilcox CS. Renal vasoconstriction during inhibition of NO synthase: effects of dietary salt. Kidney Int. 1994;46: 639-646.
23. Mattson D, Higgins DJ. Influence of dietary sodium intake on renal medullary nitric oxide synthase. Hypertension. 1996;27:688-692.
24. Villar MJ, Cecatelli S, Ronnqvist M, Hokfelt T. Nitric oxide synthase increases in hypothalamic magnocellular neurons after salt loading in the rat. An immunohistochemical and in situ hybridization study. Brain Res. 1994;644:273-281.
25. Salom MG, Lahera V, Miranda-Guardiola F, Romero JC. Blockade of pressure natriuresis induced by inhibition of renal synthesis of nitric oxide in dogs. Am J Physiol. 1992;262:F718-F722.
26. Baylis C, Harton P, Engels K. Endothelium-derived relaxing factor controls renal hemodynamics in the normal rat kidney. J Am Soc Nephrol. 1990;1:875-881.
27. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest. 1992;90:278-281.
28. Ribeiro MO, Antunes E, De-Nucci G, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension. 1992;20:298-303.
29. Arnal JF, Warin L, Michel JB. Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J Clin Invest. 1992;90:647-652.
30. Lahera V, Salazar J, Salom MG, Romero JC. Deficient production of nitric oxide induces volume-dependent hypertension. J Hypertens. 1992; 10(suppl):S173-S177.
31. Huang PL, Huang ZH, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995;377:239-242.
32. Steudel W, Ichinose F, Huang PL, Hurford WE, Jones RC, Bevan JA, Fishman MC, Zapol WM. Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene. Circ Res. 1997;81:34-41.
33. Nelson RJ, Demas GE, Huang PL, Fishman MC, Dawson VL, Dawson TM, Snyder SH. Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase. Nature. 1995;378:383-386.
34. Laubach VE, Shesely EG, Smithies O, Sherman PA. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci U S A. 1995;92:10688-10692.
35. Bonnardeaux A, Nadaud S, Charru A, Jeunemaitre X, Corvol P, Soubrier F. Lack of evidence for linkage of the endothelial cell nitric oxide synthase gene to essential hypertension. Circulation. 1995;91: 96-102.
36. Hunt SC, Williams CS, Sharma AM, Inoue I, Williams RR, Lalouel JM. Lack of linkage between the endothelial nitric oxide synthase gene and hypertension. J Hum Hypertens. 1996;10:27-30.
37. Ollerstam A, Pittner J, Persson AEG, Thorup C. Increased blood pressure in rats after long-term inhibition of the neuronal isoform of nitric oxide synthase. J Clin Invest. 1997;99:2212-2218.
38. Kumagai K, Suzuki H, Ichikawa M, Jimbo M, Murakami M, Ryuzaki M, Saruta T. Nitric oxide increases renal blood flow by interacting with the sympathetic nervous system. Hypertension. 1994;24:220-226.
39. Qiu C, Engels K, Baylis C. Angiotensin 11 and alpha 1-adrenergic tone in chronic nitric oxide blockade-induced hypertension. Am J Physiol. 1994;266:R1470-R1476.
40. Guyton AC. Long-term arterial pressure control: an analysis from animal experiments and computer and graphic models. Am J Physiol. 1990;259:R865-R877.
41. Kassab S, Miller MT, Hester R, Novak J, Granger JP. Systemic hemodynamics and regional blood flow during chronic nitric oxide synthesis inhibition in pregnant rats. Hypertension. 1998;31:315-320.
42. Sigmon DH, Carretero OA, Beierwaltes WH. Plasma renin activity and the renal response to nitric oxide synthesis inhibition. J Am Soc Nephrol. 1992;3:1288-1294.
43. Manning RD Jr, Hu LF, Williamson TD. Mechanisms involved in the cardiovascular-renal actions of nitric oxide inhibition. Hypertension. 1994;23:951-956.
44. Qiu C, Engels K, Baylis C. Endothelin modulates the pressor actions of acute systemic nitric oxide blockade. J Am Soc Nephrol. 1995;6: 1476-1481.
45. Baylis C, Harvey J, Engels K. Acute nitric oxide blockade amplifies the renal vasoconstrictor actions of angiotensin II. J Am Soc Nephrol. 1994;5:211-214.
46. Salazar FJ, Pinilla JM, Lopez F, Romero JC, Quesada T. Renal effects of prolonged synthesis inhibition of endothelium-derived nitric oxide. Hypertension. 1992;20:113-117.
47. Qiu CB, Engels K, Samsell L, Baylis C. Renal effects of acute amino acid infusion in hypertension induced by chronic nitric oxide blockade. Hypertension. 1995;25:61-66.
48. Erley CM, Rebmann S, Strobel U, Schmidt T, Wehrmann M, Osswald H, Risler T. Effects of antihypertensive therapy on blood pressure and renal function in rats with hypertension due to chronic blockade of nitric oxide synthesis. Exp Nephrol. 1995;3:293-299.
49. Morton JJ, Beattie EC, Speirs A, Gulliver F. Persistent hypertension following inhibition of nitric oxide formation in the young Wistar rat: role of renin and vascular hypertrophy. J Hypertens. 1993;11: 1083-1088.
50. Deng LY, Thibault G, Schiffrin EL. Effect of hypertension induced by nitric oxide synthase inhibition on structure and function of resistance arteries in the rat. Clin Exp Hypertens. 1993;15:527-537.
51. Fujihara CK, Michellazzo SM, De-Nucci G, Zatz R. Sodium excess aggravates hypertension and renal parenchymal injury in rats with chronic NO inhibition. Am J Physiol 1994;266:F697-F705.
52. Zanchi A, Schaad NC, Osterheld MC, Grouzmann E, Nussberger J, Brunner HR, Waeber B. Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system. Am J Physiol. 1995;268:H2267-H2273.
53. Bank N, Aynedjian HS, Khan GA. Mechanism of vasoconstriction induced by chronic inhibition of nitric oxide in rats. Hypertension. 1994;24:322-328.
54. Navarro-Cid J, Maeso R, Rodrigo E, Munoz-Garcia R, Ruilope LM, Lahera V, Cachofeiro V. Renal and vascular consequences of the chronic nitric oxide synthase inhibition. Effects of antihypertensive drugs. Am J Hypertens. 1996;9:1077-1083.
55. Takase H, Moreau P, Kung CF, Nava E, Luscher TF. Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency: effect of verapamil and trandolapril. Hypertension. 1996;27:25-31.
56. Pollock DM, Polakowski JS, Divish BJ, Opgenorth TJ. Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition. Hypertension. 1993;21:660-666.
57. Jover B, Herizi A, Ventre F, Dupont M, Mimran A. Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade. Hypertension. 1993;21:944-948.
58. Vidai MJ, Romero JC, Vanhoutte PM. Endothelium-derived relaxing factor inhibits renin release. Eur J Pharmacol. 1988;149:401-402.
59. Greenberg SG, He XR, Schnermann JB, Briggs JP. Effect of nitric oxide on renin secretion. 1. Studies in isolated juxtaglomerular granular cells. Am J Physiol. 1995;268:F948-F952.
60. Tharaux PL, Dussaule JC, Pauti MD, Vassitch Y, Ardaillou R, Chatziantoniou C. Activation of renin synthesis is dependent on intact nitric oxide production. Kidney Int. 1997;51:1780-1787.
61. Gardes J, Gonzalez MF, Alhenc-Gelas F, Menard J. Influence of sodium diet on L-NAME effects on renin release and renal vasoconstriction. Am J Physiol. 1994;267:F798-F804.
62. Yamada SS, Sassaki AL, Fujihara CK, Malheiros DM, De Nucci G, Zatz R. Effect of salt intake and inhibitor dose on arterial hypertension and renal injury induced by chronic nitric oxide blockade. Hypertension. 1996;27:1165-1172.
63. Knoblich PR, Freeman RH, Villarreal D. Pressure-dependent renin release during chronic blockade of nitric oxide synthase. Hypertension. 1996;28:738-742.
64. Qiu C, Muchant D, Beierwaltes W, Racusen L, Baylis C. Evolution of chronic nitric oxide inhibition hypertension: relationship to renal function. Hypertension. 1998;31:21-26.
65. Garcia GE, Brown MR, Wead LM, Braun S, Gabbai FB. Effect of reduction of nitric oxide on plasma and kidney tissue angiotensin II levels. Am J Hypertens. 1997;10:1103-1108.
66. G-Monomethyl-L-arginine and nitroarginine potentiate pressor responsiveness of vasoconstrictors in conscious rats. Am J Physiol. 1992;262:R1137-R1144.
67. Wilcox CS, Welch WJ, Murad F, Gross SS, Taylor G, Levi R, Schmidt HH. Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci USA. 1992;89:11993-11997.
68. Bachmann S, Bosse HM, Mundel P. Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney. Am J Physiol. 1995;268:F885-F898.
69. Beierwaltes WH. Selective neuronal nitric oxide synthase inhibition blocks furpsemide-stimulated renin secretion in vivo. Am J Physiol. 1995;269:F134-F139.
70. Beierwaltes WH. Macula densa stimulation of renin is reversed by selective inhibition of neuronal nitric oxide synthase. Am J Physiol. 1997;272:R1359-R1364.
71. Cunha RS, Cabrai AM, Vasquez EC. Evidence that the autonomic nervous system plays a major role in the L-NAME-induced hypertension in conscious rats. Am J Hypertens. 1993;6:806-809.
72. Traystman RJ, Moore LE, Helfaer MA, Davis S, Banasiak K, Williams M, Hurn PD. Nitro-L-arginine analogues. Dose-and time-related nitric oxide synthase inhibition in brain. Stroke. 1995;26:864-869.
73. Kanagy NL. Increased vascular responsiveness to alpha 2-adrenergic stimulation during NOS inhibition-induced hypertension. Am J Physiol. 1997;273:H2756-H2764.
74. ω-nitro-L-arginine methyl ester. Hypertension. 1997;30: 64-70.
75. Matsuoka H, Nishida H, Nomura G, Van Vliet BN, Toshima H. Hypertension induced by nitric oxide synthesis inhibition is renal nerve dependent. Hypertension. 1994;23:971-975.
76. G-nitro-L-arginine methyl ester treatment in conscious rats. Hypertension. 1994;23:982-986.
77. Granger J, Novak J, Schnackenberg C, Williams S, Reinhart GA. Role of renal nerves in mediating the hypertensive effects of nitric oxide synthesis inhibition. Hypertension. 1996;27:613-618.
78. Fujihara CK, De Nucci G, Zatz R. Do ETA receptors participate in the hemodynamic and renal effects of chronic nitric oxide blockade? J Cardiovasc Pharmacol. 1995;26:S462-S465.
79. Sventek P, Turgeon A, Schiffrin EL. Vascular endothelin-1 gene expression and effect on blood pressure of chronic ETA endothelin receptor antagonism after nitric oxide synthase inhibition with L-NAME in normal rats. Circulation. 1997;95:240-244.
80. Verhagen AMG, Rabelink TJ, Braam B, Opgenorth TJ, Grone HJ, Koomans HA, Joles JA. Endothelin A receptor blockade alleviates hypertension and renal lesions associated with chronic nitric oxide synthase inhibition. J Am Soc Nephrol. 1998;9:755-762.
81. Quignard JF, Frapier JM, Harricane MC, Albat B, Nargeot J, Richard S. Voltage-gated calcium channel currents in human coronary myocytes. Regulation by cyclic GMP and nitric oxide. J Clin Invest. 1997;99:185-193.
82. Meszaros LG, Minarovic I, Zahradnikova A. Inhibition of the skeletal muscle ryanodine receptor calcium release channel by nitric oxide. FEBS Lett. 1996;380:49-52.
83. Ribeiro MO, Antunes E, Muscara MN, De Nucci G, Zatz R. Nifedipine prevents renal injury in rats with chronic nitric oxide inhibition. Hypertension. 1995;26:150-155.
84. Mattson DL, Lu S, Nakanishi K, Papanek PE, Cowley AW Jr. Effect of chronic renal medullary nitric oxide inhibition on blood pressure. Am J Physiol. 1994;266:H1918-H1926.
85. Chen PY, Sanders PW. L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest. 1991;88:1559-1567.
86. Tolins JP, Shultz PJ. Endogenous nitric oxide synthesis determines sensitivity to the presser effect of salt. Kidney Int. 1994;46:230-236.
87. Salazar FJ, Alberola A, Pinilla JM, Romero JC, Quesada T. Salt-induced increase in arterial pressure during nitric oxide synthesis inhibition. Hypertension. 1993;22:49-55.
88. Fernandez-Rivas A, Garcia-Estan J, Vargas F. Effects of chronic increased salt intake on nitric oxide synthesis inhibition-induced hypertension. J Hypertens. 1995;13:123-128.
89. Salvemini D, Masferrer JL. Interactions of nitric oxide with cyclooxygenase: in vitro, ex vivo and in vivo studies. Methods Enzymol. 1996; 269:12-25.
90. Marotta P, Sautebin L, Di Rosa M. Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774. Br J Pharmacol. 1992;107:640-641.
91. Luckhoff A, Mulsch A, Busse R. cAMP attenuates autocoid release from endothelial cells: relation to internal calcium. Am J Physiol. 1990;258: H960-H966.
92. G-monomethyl-L-arginine and L-arginine on acetylcholine renal response. Hypertension. 1990;15:659-663.
93. Baylis C, Slangen B, Hussain S, Weaver C. Relationship between basal NO release and cyclooxygenase products in the normal rat kidney. Am J Physiol. 1996;271:R1327-R1334.
94. Harder DR, Lange AR, Gebremedhin D, Birks EK, Roman RJ. Cytochrome P450 metabolites of arachidonic acid as intracellular signaling molecules in vascular tissue. J Vasc Res. 1997;34:237-243.
95. Nakatsuka M, Osawa Y. Selective inhibition of the 12-lipoxygenase pathway of arachidonic acid metabolism by L-arginine or sodium nitroprusside in intact human platelets. Biochem Biophys Res Commun. 1994;200:1630-1634.
96. Nicotera P, Brune B, Bagetta G. Nitric oxide: inducer or suppressor of apoptosis? Trends Pharmacol Sci. 1997;18:189-190.
97. Dubey RK, Jackson EK, Rupprecht HD, Sterzel RB. Factors controlling growth and matrix production in vascular smooth muscle and glomerular mesangial cells. Curr Opin Nephrol Hypertens. 1997;6:88-105.
98. Moreno H, Metze K, Bento AC, Antunes E, Zatz R, De Nucci G. Chronic nitric oxide inhibition as a model of hypertensive heart muscle disease. Basic Res Cardiol. 1996;91:248-255.
99. Banting JD, Thompson KE, Friberg P, Adams MA. Blunted cardiovascular growth induction during prolonged nitric oxide synthase blockade. Hypertension. 1997;30:416-421.
100. Heptinstall RH. Hypertension. In: Heptinstall RH, ed. Pathology of the Kidney. Boston, Mass: Little Brown & Co; 1983:1347-1454.
101. Meyer TW, Rennke HG. Progressive glomerular injury after limited renal infarction in the rat. Am J Physiol. 1988;254:F856-F862.
102. Arcos MI, Fujihara C, Sesso A, Prado EBA, Prado MJA, Vasques W, Correia H, De Nucci G, Zatz R. Mechanisms of proteinuria in the chronic nitric oxide inhibition model. J Am Soc Nephrol. 1996;7:1558. Abstract.
103. Numaguchi K, Egashira K, Takemoto M, Kadokami T, Shimokawa H, Sueishi K, Takeshita A. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats. Hypertension. 1995; 26:957-962.
104. Moreno H, Nathan LP, Costa SKP, Metze K, Antunes E, Zatz R, De Nucci G. Enalapril does not prevent the myocardial ischemia caused by the chronic inhibition of nitric oxide synthesis. Eur. J Pharmacol. 1995;287:93-96.
105. Ikeda K, Gu D, Nara Y, Tagami M, Yamori Y. New stroke model from normotensive Wistar-Kyoto rats by chronic nitric oxide synthesis inhibition. J Hypertens. 1994;12(suppl 3):S3. Abstract.
106. Blot S, Arnal JF, Xu Y, Gray F, Michel JB. Spinal cord infarcts during long-term inhibition of nitric oxide synthase in rats. Stroke. 1994;25: 1666-1673.